Overview

Effects of Famotidine on the Pharmacokinetics of Atazanavir When Coadministered to Participants With HIV Infection

Status:
Completed
Trial end date:
2011-06-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess the effects of famotidine, given twice daily, on atazanavir administered with ritonavir and tenofovir in HIV-infected participants.
Phase:
Phase 4
Details
Lead Sponsor:
Bristol-Myers Squibb
Treatments:
Atazanavir Sulfate
Famotidine
Reverse Transcriptase Inhibitors
Ritonavir
Tenofovir